Expression and role of microRNA-375 in cancer

doi:10.3760/cma.j.issn.1673-422X.2016.06.011

Abstract

Abstract: MicroRNA-375 (miR-375) is closely related to the development of cancer, such as liver cancer, gastric cancer, pancreatic cancer, endometrial cancer, esophageal cancer, non-small cell lung cancer, etc. The mainly tumor pathogenesis related miR375 includes that miR375 is combined with specific target genes, can degrade mRNA or inhibit protein translation in the transcriptional level, and plays antitumor effect of inhibition of cell proliferation, promoting cell apoptosis and inhibiting the invasion and metastasis. miR375 is expected to be a new target for cancer therapy, which may become an important biomarker for the diagnosis, treatment and prognosis of cancer.

Key words: MicroRNAs, Neoplasms

Liu Yang, Chen Nan, Pang Jinqiao, Xiong Chengxiu, Li Gaofeng. Expression and role of microRNA-375 in cancer[J]. Journal of International Oncology, 2016, 43(6): 442-444.

References

［1］ Shao Y, Geng Y, Gu W, et al. Prognostic significance of microRNA375 downregulation in solid tumors: a metaanalysis［J］. Dis Markers, 2014, 2014: 626185. DOI: 10.1155/2014/626185. ［2］ Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship［J］. Nat Rev Genet, 2012, 13(4): 271-282. DOI: 10.1038/nrg3162. ［3］ Shrestha S, Hsu SD, Huang WY, et al. A systematic review of microRNA expression profiling studies in human gastric cancer［J］. Cancer Med, 2014, 3(4): 878-888. DOI: 10.1002/cam4.246. ［4］ Wang L, Song G, Liu M, et al. MicroRNA375 overexpression influences P19 cell proliferation, apoptosis and differentiation through the Notch signaling pathway［J］. Int J Mol Med, 2016, 37(1): 47-55. DOI: 10.3892/ijmm.2015.2399. ［5］ Ding L, Xu Y, Zhang W, et al. MiR375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2［J］. Cell Res, 2010, 20(7): 784-793. DOI: 10.1038/cr.2010.79. ［6］ Tsukamoto Y, Nakada C, Noguchi T, et al. MicroRNA375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 1433zeta［J］. Cancer Res, 2010, 70(6): 2339-2349. DOI: 10.1158/00085472.CAN-09-2777. ［7］ Xu Y, Jin J, Liu Y, et al. Snailregulated miR375 inhibits migration and invasion of gastric cancer cells by targeting JAK2［J］. PLoS One, 2014, 9(7): e99516. DOI: 10.1371/journal.pone. 0099516. ［8］ Miao L, Liu K, Xie M, et al. MiR375 inhibits Helicobacter pyloriinduced gastric carcinogenesis by blocking JAK2STAT3 signaling［J］. Cancer Immunol Immunother, 2014, 63(7): 699-711. DOI: 10.1007/s00262-014-1550-y. ［9］ He XX, Chang Y, Meng FY, et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo［J］. Oncogene, 2012, 31(28): 3357-3369. DOI: 10.1038/onc.2011.500. ［10］ Yang T, Zhao P, Rong Z, et al. Antitumor efficiency of lipidcoated cisplatin nanoparticles coloaded with microRNA375［J］. Theranostics, 2016, 6(1): 142-154. DOI: 10.7150/thno.13130. ［11］ Jung HI, Ahn T, Bae SH, et al. Astrocyte elevated gene1 overexpression in hepatocellular carcinoma: an independent prognostic factor［J］. Ann Surg Treat Res, 2015, 88(2): 7785. DOI: 10.4174/astr.2015.88.2.77. ［12］ Song S, Zhou J, He S, et al. Expression levels of microRNA375 in pancreatic cancer［J］. Biomed Rep, 2013, 1(3): 393-398. ［13］ Li W, Lebrun DG, Li M, et al. The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma［J］. Chin J Cancer, 2011, 30(8): 540-550. DOI: 10.5732/cjc.011.10197. ［14］ Zhou J, Song S, He S, et al. MicroRNA375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway［J］. Int J Mol Med, 2014, 33(4): 950956. DOI: 10.3892/ijmm.2014.1638. ［15］ Xu L, Li M, Wang M, et al. The expression of microRNA375 in plasma and tissue is matched in human colorectal cancer［J］. BMC Cancer, 2014, 14(1): 714. DOI: 10.1186/1471-2407-14-714. ［16］ Wang Y, Tang Q, Li M, et al. MicroRNA375 inhibits colorectal cancer growth by targeting PIK3CA［J］. Biochem Biophys Res Commun, 2014, 444(2): 199204. DOI: 10.1016/j.bbrc.2014.01.028. ［17］ Kong KL, Kwong DL, Chan TH, et al. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulinlike growth factor 1 receptor［J］. Gut, 2012, 61(1): 33-42. DOI: 10.1136/gutjnl-2011-300178. ［18］ Li X, Lin R, Li J. Epigenetic silencing of microRNA375 regulates PDK1 expression in esophageal cancer［J］. Dig Dis Sci, 2011, 56(10): 2849-2856. DOI: 10.1007/s10620-011-1711-1. ［19］ Isozaki Y, Hoshino I, Akutsu Y, et al. Usefulness of microRNA375 as a prognostic and therapeutic tool in esophageal squamous cell carcinoma［J］. Int J Oncol, 2015, 46(3): 1059-1066. DOI: 10.3892/ijo.2014.2789. ［20］ Shen Y, Wang P, Li Y, et al. miR375 is upregulated in acquired paclitaxel resistance in cervical cancer［J］. Br J Cancer, 2013, 109(1): 92-99. DOI: 10.1038/bjc.2013.308. ［21］ Shen Y, Zhou J, Li Y, et al. MiR375 mediated acquired chemoresistance in cervical cancer by facilitating EMT［J］. PLoS One, 2014, 9(10): e109299. DOI: 10.1371/journal.pone.0109299. ［22］叶文蔚, 李甫钥, 叶夏斌, 等. MiR375在子宫内膜癌HEC1B细胞中的生物学功能［J］. 实用医学杂志, 2013, 29(2): 177-180. ［23］ Jin Y, Liu YL, Zhang J, et al. The expression of miR375 is associated with carcinogenesis in three subtypes of lung cancer［J］. PLoS One, 2015, 10(12): e0144187. DOI: 10.1371/journal.pone.0144187.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.